Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in acute spinal cord injury
NCT01597518Phase 3Terminated
- Sponsor
- AO Spine North America Research Network
- Start
- Oct 2013
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of riluzole in traumatic spinal cord injury (TSCI), sponsored by AO Spine North America Research Network. Started Oct 2013; status: terminated.
02
Drugs
riluzole
03
Conditions
traumatic spinal cord injury (TSCI)
Beyond the preview
Go deeper on NCT01597518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597518.